- > Media & Investors
- > Media Relations
- > Press Releases
- > Daiichi Sankyo Listed on the Dow Jones Sustainability Indices World Index
For Immediate Release
Company name: DAIICHI SANKYO COMPANY, LIMITED
Representative: Sunao Manabe, Representative Director, President and COO
(Code no.: 4568, First Section, Tokyo Stock Exchange)
Please address inquiries to Noriaki Ishida, Executive Officer,
Vice President, Corporate Communications Department
Daiichi Sankyo Listed on the Dow Jones Sustainability Indices World Index
Tokyo, Japan (September15, 2017) – Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that it has been listed on the Dow Jones Sustainability Indices (DJSI) *1 World Index (DJSI World), the world’s leading ESG investment*2 index as the first Japanese company from the pharmaceutical sector.
This year Daiichi Sankyo was the only Japanese company among eight pharmaceutical companies in the sector to be listed on DJSI World, which includes 319 companies, of which 32 are Japanese.
Daiichi Sankyo has also been listed on the DJSI Asia Pacific for eight consecutive years.
Within DJSI World, Daiichi Sankyo received the top score among the pharmaceutical sector for Environmental Dimension including Climate Strategy. The Company was also recognized for its strong performance in the areas of Codes of Business Conduct and Materiality*3 in Economic Dimension, Health Outcome Contribution, Occupational Health and Safety and Strategy to Improve Access to Drugs in Social Dimension.
In addition to the DJSI, Daiichi Sankyo has also been included in FTSE4Good Index for nine consecutive years, which is also a global ESG index, and the Morningstar Socially Responsible Investment Index by Morningstar Japan for ten consecutive years.
Daiichi Sankyo will continue to make every effort to put into practice our corporate mission, “To contribute to the enrichment of quality of life around the world through the creation of innovative pharmaceuticals, and through the provision of pharmaceuticals addressing diverse medical needs,” while fulfilling our social responsibility by performing CSR activities that appropriately respond to sustainability challenges as we aim to continuously enhance corporate value.
*1: Dow Jones Sustainability Indices (DJSI) : The global indices from S&P Dow Jones Indices LLC of the USA and RobecoSAM AG of Switzerland which assess and select leading, sustainability-driven companies worldwide in terms of environmental, social and governance performances. This is one of the important investment standards for institutional investors who emphasize financially material Environmental, Social, and Governance (ESG) factors along with the financial information.
*2: ESG investment: An investment based on criteria that assess a company’s performance from social, ethical and environmental perspectives, in addition to financial analysis.
*3: Materiality: CSR Issues and Initiatives that the Company has prioritized.